BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36639964)

  • 21. Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.
    Ciuffi S; Cianferotti L; Nesi G; Luzi E; Marini F; Giusti F; Zonefrati R; Gronchi G; Perigli G; Brandi ML
    Endocr J; 2019 Apr; 66(4):319-327. PubMed ID: 30799315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic defects associated with familial and sporadic hyperparathyroidism.
    Hendy GN; Cole DE
    Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family.
    Cascón A; Huarte-Mendicoa CV; Javier Leandro-García L; Letón R; Suela J; Santana A; Costa MB; Comino-Méndez I; Landa I; Sánchez L; Rodríguez-Antona C; Cigudosa JC; Robledo M
    Genes Chromosomes Cancer; 2011 Nov; 50(11):922-9. PubMed ID: 21837707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of
    Gheorghe AM; Sima OC; Florescu AF; Ciuche A; Nistor C; Sandru F; Carsote M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A large extended family with hyperparathyroidism-jaw tumor syndrome due to deletion of the third exon of CDC73: clinical and molecular features.
    Le Collen L; Barraud S; Braconnier A; Coppin L; Zachar D; Boulagnon C; Deguelte S; Souchon PF; Spodenkiewicz M; Poirsier C; Aubert S; Odou MF; Delemer B
    Endocrine; 2021 Sep; 73(3):693-701. PubMed ID: 33999366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 gene.
    Pazienza V; la Torre A; Baorda F; Alfarano M; Chetta M; Muscarella LA; Battista C; Copetti M; Kotzot D; Kapelari K; Al-Abdulrazzaq D; Perlman K; Sochett E; Cole DE; Pellegrini F; Canaff L; Hendy GN; D'Agruma L; Zelante L; Carella M; Scillitani A; Guarnieri V
    PLoS One; 2013; 8(12):e82292. PubMed ID: 24340015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [CDC73 mutations in young patients with primary hyperparathyroidism: A description of two clinical cases].
    Mamedova EO; Mokrysheva NG; Pigarova EA; Przhiyalkovskaya EG; Voronkova IA; Vasilyev EV; Petrov VM; Gorbunova VA; Rozhinskaya LY; Belaya ZE; Tyulpakov AN
    Ter Arkh; 2016; 88(10):57-62. PubMed ID: 27801421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyper Parathyroidisim Jaw Tumor Syndrome: A Rare Condition of Incongruous Features.
    Redwin Dhas MP; Karthiga KS; Tatu JE; Eugenia SJ
    Ethiop J Health Sci; 2017 May; 27(3):309-313. PubMed ID: 29217931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OVARIAN GRANULOSA CELL TUMOR IN A PATIENT WITH A PATHOGENIC VARIANT IN THE
    Sirbiladze RL; Uyar D; Geurts JL; Shaker JL
    AACE Clin Case Rep; 2019; 5(3):e222-e225. PubMed ID: 31967039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features.
    Gill AJ; Lim G; Cheung VKY; Andrici J; Perry-Keene JL; Paik J; Sioson L; Clarkson A; Sheen A; Luxford C; Elston MS; Meyer-Rochow GY; Nano MT; Kruijff S; Engelsman AF; Sywak M; Sidhu SB; Delbridge LW; Robinson BG; Marsh DJ; Toon CW; Chou A; Clifton-Bligh RJ
    Am J Surg Pathol; 2019 Jan; 43(1):35-46. PubMed ID: 29324469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred.
    Iacobone M; Masi G; Barzon L; Porzionato A; Macchi V; Ciarleglio FA; Palù G; De Caro R; Viel G; Favia G
    Langenbecks Arch Surg; 2009 Sep; 394(5):817-25. PubMed ID: 19529956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperparathyroidism-jaw tumor syndrome: Results of operative management.
    Mehta A; Patel D; Rosenberg A; Boufraqech M; Ellis RJ; Nilubol N; Quezado MM; Marx SJ; Simonds WF; Kebebew E
    Surgery; 2014 Dec; 156(6):1315-24; discussion 1324-5. PubMed ID: 25444225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIGH RISK OF PARATHYROID CARCINOMA AND GENETIC SCREENING IN THE FIRST DIAGNOSED ROMANIAN FAMILY WITH HYPERPARATHYROIDISM-JAW TUMOR SYNDROME AND A GERMLINE MUTATION OF THE CDC73 GENE.
    Grigorie D; Sucaliuc A; Ciuffi S; Franceschelli F; Marini F; Ioachim D; Terzea D; Brandi MLL
    Acta Endocrinol (Buchar); 2019; 15(3):398-403. PubMed ID: 32010362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations.
    Iacobone M; Camozzi V; Mian C; Pennelli G; Pagetta C; Casal Ide E; Masi G; Zovato S; Torresan F
    World J Surg; 2020 Feb; 44(2):508-516. PubMed ID: 31493194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.
    Newey PJ; Bowl MR; Cranston T; Thakker RV
    Hum Mutat; 2010 Mar; 31(3):295-307. PubMed ID: 20052758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary hyperparathyroidism and jaw tumor syndrome: a novel mutation of the HRPT2 gene.
    Carlson AL; Smith CL
    Endocr Pract; 2008 Sep; 14(6):743-7. PubMed ID: 18996796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism.
    Starker LF; Akerström T; Long WD; Delgado-Verdugo A; Donovan P; Udelsman R; Lifton RP; Carling T
    Horm Cancer; 2012 Apr; 3(1-2):44-51. PubMed ID: 22187299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors.
    Vocke CD; Ricketts CJ; Ball MW; Schmidt LS; Metwalli AR; Middelton LA; Killian JK; Khan J; Meltzer PS; Simonds WF; Merino MJ; Linehan WM
    Urology; 2019 Feb; 124():91-97. PubMed ID: 30452964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma.
    Korpi-Hyövälti E; Cranston T; Ryhänen E; Arola J; Aittomäki K; Sane T; Thakker RV; Schalin-Jäntti C
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3044-8. PubMed ID: 24823466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome.
    Simonds WF; Robbins CM; Agarwal SK; Hendy GN; Carpten JD; Marx SJ
    J Clin Endocrinol Metab; 2004 Jan; 89(1):96-102. PubMed ID: 14715834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.